Inspira Technologies Oxy B.H.N. Stock (NASDAQ:IINN)
Previous Close
$0.99
52W Range
$0.80 - $2.45
50D Avg
$1.15
200D Avg
$1.41
Market Cap
$18.17M
Avg Vol (3M)
$699.56K
Beta
2.09
Div Yield
-
IINN Company Profile
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
IINN Performance
Peer Comparison
Ticker | Company |
---|---|
NURO | NeuroMetrix, Inc. |
IRIX | IRIDEX Corporation |
LNSR | LENSAR, Inc. |
SGHT | Sight Sciences, Inc. |
NAOV | NanoVibronix, Inc. |
RSLS | ReShape Lifesciences Inc. |
NPCE | NeuroPace, Inc. |
SSKN | STRATA Skin Sciences, Inc. |
BBLG | Bone Biologics Corporation |
VVOS | Vivos Therapeutics, Inc. |
SRDX | Surmodics, Inc. |
TIVC | Tivic Health Systems, Inc. |
AIMD | Ainos, Inc. |
BJDX | Bluejay Diagnostics, Inc. |
HSCS | Heart Test Laboratories, Inc. |